Skip to main content
Log in

Glycosylated haemoglobin levels in breast cancer patients receiving cytotoxic chemotherapy

  • Correspondence
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Jovanovic L, Peterson CM: The clinical utility of glycosylated haemoglobin. Am J Med 70: 331–338, 1981

    PubMed  Google Scholar 

  2. Snyder S, Ashwell G: Quantitation of specific serum glycoproteins in malignancy. Clin Chim Acta 34: 449–455, 1971

    PubMed  Google Scholar 

  3. Mattison P, Cove DH, Walsh L, Howell A, McConkey B, Morrison JM: Serum proteins as tumour markers for breast cancer. Br J Cancer 43: 542–545, 1981

    PubMed  Google Scholar 

  4. Hogan-Ryan A, Fennely JJ, Jones M, Cantwell B, Duffy MJ: Serum sialic acid and CEA concentrations in human breast cancer. Br J Cancer 41: 587–592, 1980

    PubMed  Google Scholar 

  5. Davis JC, Hipkin LJ, Finn R, St Hill CA: Do plasma glycoproteins induce lymphocyte hyporesponsiveness and insulin resistance? Lancet ii: 1343–1345, 1978

    Google Scholar 

  6. Kocak M, Hipkin LJ, Davis JC: Glycosylated haemoglobins in advanced malignancy. Europ J Cancer 17: 123–124, 1980

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cantwell, B., Shirley, I.F. & Fennelly, J.J. Glycosylated haemoglobin levels in breast cancer patients receiving cytotoxic chemotherapy. Breast Cancer Res Tr 1, 281–282 (1981). https://doi.org/10.1007/BF01806270

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806270

Keywords

Navigation